Resveratrol protects against arsenic trioxide-induced cardiotoxicity in vitro and in vivo

BACKGROUND AND PURPOSE: The clinical use of arsenic trioxide (As(2)O(3)), a potent antineoplastic agent, is limited by its severe cardiotoxic effects. QT interval prolongation and apoptosis have been implicated in the cardiotoxicity of As(2)O(3). The present study was designed to evaluate the effect...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Zhao, X-Y, Li, G-Y, Liu, Y, Chai, L-M, Chen, J-X, Zhang, Y, Du, Z-M, Lu, Y-J, Yang, B-F
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2008
Gaiak:
Research Papers
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2438979/
https://ncbi.nlm.nih.gov/pubmed/18332854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjp.2008.81
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak